title: Hemostatic effects of omega-3 fatty acids in isolated hypertriglyceridemic patients treated with bezafibrate.
authors.forename: Robert
authors.initials: R
authors.lastname: Krysiak
authors.forename: Boguslaw
authors.initials: B
authors.lastname: Okopien
mesh_terms: D000328:Adult; D000368:Aged; D000941:Antigens / Q000097:blood; D001629:Bezafibrate / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005167:Factor VII; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D015228:Hypertriglyceridemia / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D011517:Prothrombin Time; D014841:von Willebrand Factor / Q000032:analysis
chemical_list: D000941:Antigens; D015525:Fatty Acids, Omega-3; D000960:Hypolipidemic Agents; D017395:Plasminogen Activator Inhibitor 1; C042580:factor VII clotting antigen; D014841:von Willebrand Factor; D005167:Factor VII; D005340:Fibrinogen; D001629:Bezafibrate